ArticleReproductive medicine and biology
Optimizing Non-Invasive PGT-A: A Multi-Factorial Approach for Enhanced Accuracy and Seamless Integration Into Clinical IVF.
Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to identify factors influencing the accuracy and effectiveness of non-invasive preimplantation genetic testing for aneuploidy (niPGT-A) and develop clinical integration workflows to provide alternative embryo assessment and improve pregnancy outcomes. Methods: A two-phase study analyzed 341 blastocysts and spent culture medium (SCM) from 90 IVF patients. Phase 1 assessed niPGT-A accuracy by comparing SCM/trophectoderm (TE) with whole blastocysts (100 frozen embryos). Phase 2 examined concordance, assisted hatching, and culture-duration effects, focusing on outcomes after frozen embryo transfer using 241 fresh embryos. Nineteen euploid-TE/euploid-SCM and 14 euploid-TE/aneuploid-SCM blastocysts were transferred, and a meta-analysis was conducted using data from 163 euploid embryos across four studies. Results: The optimized niPGT-A workflow achieved a superior PPV of 92.1% and accuracy of 91.3%, outperforming conventional PGT-A. Ploidy and sex concordances were 76.5% and 98.9% among 183 fresh embryos. Assisted hatching improved amplification rates, while culture duration/ploidy did not impact concordance. Meta-analysis showed SCM-guided embryo transfer significantly improved pregnancy outcomes, compared to TE biopsy. Conclusion: This optimized niPGT-A procedure provides a highly accurate chromosomal assessment, seamlessly integrates with IVF workflows. It supports informed embryo transfer decisions, improves outcomes, reduces embryo damage risk, and limits invasive procedures, enhancing clinical management in reproductive medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.